ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Introducing drug-anti-body conjugates"
Episode Synopsis
Dr Lizanne Langenhoven details how knowing the subtype of breast cancer determines treatment, and introduces the new drug-antibody conjugates for HER2-positive breast cancer.
Dr Lizanne Langenhoven is a clinical and radiation oncologist at Panorama Mediclinic and forms part of a multi-disciplinary unit of excellence in the treatment of breast cancer at the Panorama Centre for Surgical Oncology. Facebook · Twitter · Instagram · LinkedIn
Dr Lizanne Langenhoven is a clinical and radiation oncologist at Panorama Mediclinic and forms part of a multi-disciplinary unit of excellence in the treatment of breast cancer at the Panorama Centre for Surgical Oncology. Facebook · Twitter · Instagram · LinkedIn
More episodes of the podcast Buddies For Life
Welcome to Buddies for Life
02/12/2025
When desire feels out of reach
30/11/2025
How movement helps reduce tumour growth
30/11/2025
Melany Le Roux - reset and embrace life anew
30/11/2025
Your nipple and areola choices
30/11/2025
The ugly five
30/11/2025
Praise accelerated grace
30/11/2025
Why we keep believing in better days
30/11/2025
In God we trust